Insider Trading & Ownership of Chris Degnan

Location
West Chester, PA
Summary
The estimated net worth of Chris Degnan is at least $49,118 dollars as of 03 Feb 2026. Chris Degnan is the Chief Financial Officer of UroGen Pharma Ltd. and owns shares of UroGen Pharma Ltd. (URGN) stock worth about $38.4K. Chris Degnan is the Chief Financial Officer of Galera Therapeutics, Inc. and owns shares of Galera Therapeutics, Inc. (GRTX) stock worth about $10.7K.
Signature
/s/ Jason D. Smith, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Chris Degnan and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Chris Degnan has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $49,118.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: UroGen Pharma Ltd. ($38,418).
  • Past-year value change for that position: -$37,121.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Chris Degnan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
URGN UroGen Pharma Ltd. Chief Financial Officer $38,418 -$37,121 -49% 31 Jan 2026
GRTX Galera Therapeutics, Inc. Chief Financial Officer $10,700 13 Mar 2023

Insider Transactions Reported by Chris Degnan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .